Diagnosis Value of Membrane Glycolipids Biochemistry Index in Intracranial and Gastrointestinal Tumors

  • Lv, Jun (Department of Biochemistry, Wannan Medical College) ;
  • Lv, Can-Qun (Department of Biochemistry, Wannan Medical College) ;
  • Mei, Ping (Department of Biochemistry, Wannan Medical College) ;
  • Qi, Shi-Mei (Department of Biochemistry, Wannan Medical College)
  • 발행 : 2015.04.14


The diagnostic value of membrane glycolipid biochemistry index, the lipid-bound sialic acid (LSA) and total sialic acid (TSA) in cerebrospinal fluid (CSF) was evaluated in 30 intracranial and 65 gastrointestinal tumors. The plasma LSA, TSA and red cell membrane sialic acid (R-SA) in were determined according to the method of Sevenmerhulm. Our results showed that the levels of LSA and TSA in CSF of intracranial tumor patients was higher than that of normal group(p<0.01). The concentration of TSA and LSA in patients with malignant glioma was higher than that of benign meningioma patients(P<0.01). No significance was found between intracranial halmatoma patients and normal control group for levels of membrane glycolipids (p>0.05). Results also found that the plasma LSA, TSA and R-SA of gastric carcinoma were significantly higher than those of control group (p<0.05); while no significant difference was found in the plasma LSA, TSA and R-SA levels between chronic gastritis, gastrohelcoma and normal control group (p>0.05). Plasma LSA, TSA and R-SA levels of gastric carcinoma patient were significantly higher than those of chronic gastritis patients and gastrohelcoma patients(p<0.05). It was also found that plasma LSA, TSA and R-SA contents were significantly higher in large intestine carcinoma patients than in benign in stestine tumor patients (p<0.05) while no significant difference was found between intestine benign tumor and normal control group (p>0.05). The levels of LSA, TSA and R-SA were obviously higher in the patients with metastasis than in the ones without (p<0.05.) The membrane glycolipid biochemistry index LSA and TSA in CSF are sensive markers for diagnosing intracranial tumors. For gastrointestinal malignant tumors the plasma LSA TSA and red blood cell membrane SA may be considered as auxiliary indicators for diagnosis. They can be used for distinguishing benign from malignant tumors.


연구 과제 주관 기관 : national natural science foundation of china


  1. Ariga T, Yanagisawa M, Wakade C, et al (2010). Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1alpha antigens in the brain. ASN Neuro, 2, 44.
  2. Baenke F, Peck B, Miess H, et al (2013). Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech, 6, 1353-63.
  3. Banda K, Gregg CJ, Chow R, et al (2012). Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid. J Biol Chem, 287, 28852-64.
  4. Basu S, Ma R, Moskal JR, et al (2012). Ganglioside biosynthesis in developing brains and apoptotic cancer cells: X. regulation of glyco-genes involved in GD3 and Sialyl-Lex/a syntheses. Neurochem Res, 37, 1245-55.
  5. Byers DM, Gorbet JC, Irwin LN (2012). Disialogangliosides and TNFalpha alter gene expression for cytokines and chemokines in primary brain cell cultures. Neurochem Res, 37, 214-22.
  6. Gilbert ER, Eby JM, Hammer AM, et al (2013). Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis. Am J Pathol, 183, 226-34.
  7. Iijima R, Takahashi H, Namme R, et al (2004). Novel biological function of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger. FEBS Lett, 561, 163-6.
  8. Lacomba R, Salcedo J, Alegria A, et al (2011). Effect of simulated gastrointestinal digestion on sialic acid and gangliosides present in human milk and infant formulas. J Agric Food Chem, 59, 5755-62.
  9. Mansson JE, Fredman P, Nilsson O, et al (1985). Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma. Biochim Biophys Acta, 834, 110-7.
  10. Park JE, Wu DY, Prendes M, et al (2008). Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand. Immunology, 123, 145-55.
  11. Pyo H, Joe E, Jung S, et al (1999). Gangliosides activate cultured rat brain microglia. J Biol Chem, 274, 34584-9.
  12. Radic B, Vukelic Z, Bognar SK (2008). Serum gangliosides in patients with brain tumors. Coll Antropol, 32, 171-5.
  13. Rathod SR, Khan F, Kolte AP, et al (2014). Estimation of salivary and serum total sialic Acid levels in periodontal health and disease. J Clin Diagn Res, 8, 19-21.
  14. Rusnati M, Tanghetti E, Urbinati C, et al (1999). Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. Mol Biol Cell, 10, 313-27.
  15. Sagawa J, Miyagi T, Tsuiki S (1988). Membrane-associated sialidase of rat liver and its decrease in hepatomas. Jpn J Cancer Res, 79, 69-73.
  16. Schiopu C, Flangea C, Capitan F, et al (2009). Determination of ganglioside composition and structure in human brain hemangioma by chip-based nanoelectrospray ionization tandem mass spectrometry. Anal Bioanal Chem, 395, 2465-77.
  17. Stringou E, Chondros K, Kouvaris J, et al (1992). Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy. Anticancer Res, 12, 251-5.
  18. Suzuki Y, Yanagisawa M, Ariga T, et al (2011). Histone acetylation-mediated glycosyltransferase gene regulation in mouse brain during development. J Neurochem, 116, 874-80.
  19. Yin X, Xiang T, Li L, et al (2013). DACT1, an antagonist to Wnt/beta-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer Res, 15, 23.